The latest price list of Bosutinib

Bosutinib is a drug for the treatment of chronic myelogenous leukemia (CML). The price of the original drug is not yet clear in China because the original version of the drug has not yet been launched in the Chinese market. Therefore, the specific selling price of bosutinib in China is still unclear. However, the price of bosutinib in overseas markets has been relatively public, and there are certain differences in prices depending on different versions and markets.

The price of the original drug of bosutinib in overseas markets varies greatly. For example, the price of the Turkish version of bosutinib in 500mg format of 28 tablets per box is roughly more than 2,000 yuan. This price is relatively affordable and suitable for some patients who want to purchase drugs overseas. However, in regions such as Europe and Switzerland, the price of bosutinib’s original drug is relatively high. The European and Swiss versions are usually priced at more than 20,000 yuan per box. Prices may fluctuate due to factors such as exchange rate fluctuations and tax policies in these countries, so patients should pay attention to these changes when purchasing.

In addition, generic versions of bosutinib are also available on the market. For example, the specification of the bosutinib generic drug produced in India is 100mg*120 tablets per box, and the price is approximately more than 1,000 yuan. Since generic drugs have similar ingredients and effects to original drugs and are relatively cheap, some patients choose to use generic drugs for treatment. However, patients should be careful when choosing drugs to ensure that the generic drugs they purchase meet relevant drug quality standards.

Generally speaking, there are certain differences in the price of bosutinib in overseas markets. The price of imported original drugs is higher, especially in regions such as Europe and Switzerland. Generic drugs provide a more affordable option, especially those produced in India, which are relatively affordable and suitable for patients with limited budgets. As the use of bosutinib gradually increases globally, its price may be adjusted in the future as market demand and supply chain changes. When purchasing, you should choose formal channels to ensure drug quality and therapeutic effect.

Reference materials:https://go.drugbank.com/drugs/DB06616